Nighttime hemodynamic phenotype. A novel risk factor for cardiovascular disease, especially heart failure: the practitioner-based nationwide JAMP study

The Measurement of Observer Agreement for Categorical Data

J. Richard Landis, Gary G. Koch · Biometrics · 1977 · 78.9K citations · Full text

Public Health, Biostatistics, Categorical Data Analysis +12

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Karl Swedberg, Michel Komajda, Michael Böhm et al. · The Lancet · 2010 · 2.6K citations · Full text

Medicine, Cardiology, Pharmacology +11

European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring

Eoin OʼBrien, Gianfranco Parati, George S. Stergiou et al. · Journal of Hypertension · 2013 · 1.4K citations

Medicine, Cardiology, Internal Medicine +17

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy

Jean‐Claude Tardif, Eileen O’Meara, Michel Komajda et al. · European Heart Journal · 2011 · 301 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis

Kazuomi Kario, Satoshi Hoshide, Hiroyuki Mizuno et al. · Circulation · 2020 · 298 citations · Full text

Medicine, Cardiology, Clinical Cardiology +15